Shares of ImmuPharma plc (LON:IMM – Get Free Report) were down 5.6% on Friday . The stock traded as low as GBX 1.03 ($0.01) and last traded at GBX 1.15 ($0.01). Approximately 845,057 shares traded hands during trading, a decline of 7% from the average daily volume of 911,549 shares. The stock had previously closed at GBX 1.22 ($0.02).
ImmuPharma Price Performance
The business has a 50 day simple moving average of GBX 1.38 and a 200-day simple moving average of GBX 1.66. The stock has a market capitalization of £5.00 million, a price-to-earnings ratio of -120.00 and a beta of 1.53.
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Featured Stories
- Five stocks we like better than ImmuPharma
- How to Plot Fibonacci Price Inflection Levels
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- NYSE Stocks Give Investors a Variety of Quality Options
- Nebius Group: The Rising Star in AI Infrastructure
- Stock Analyst Ratings and Canadian Analyst Ratings
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
